RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 11 analysts with an average price target of $253.85. This is a potential upside of $18.31 (11.12%) from yesterday's end of day stock price of $228.44.

ResMed's activity chart (see below) currently has 219 price targets and 231 ratings on display. The stock rating distribution of RMD is 68.75% BUY and 31.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.53% with an average time for these price targets to be met of 189.27 days.

Highest price target for RMD is $321, Lowest price target is $215, average price target is $253.85.

Most recent stock forecast was given by NATHAN TREYBECK from WELLS FARGO on 07-Aug-2026. First documented stock forecast 27-Jun-2013.

Currently out of the existing stock ratings of RMD, 22 are a BUY (68.75%), 10 are a HOLD (31.25%).

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Oct-2025

$215

$-9.46 (-4.21%)

$225

Buy Since 06-Feb-2024

$255

$30.54 (13.61%)

$290

Hold Since 07-Aug-2026

$244

$19.54 (8.71%)

$234

Hold Since 10-Jan-2025

$225

$0.54 (0.24%)

$275

Buy Since 14-Apr-2023

$220

$-4.46 (-1.99%)

$300

Show more analysts

Please expand the browser size to see the chart

What is RMD (ResMed) average time for price targets to be met?

On average it took 189.27 days on average for the stock forecasts to be realized with a an average price target met ratio 73.53

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan has 2 price targets and 4 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Craig Wong-Pan with highest potential upside - $120.71

Which analyst is the currently most reserved on RMD (ResMed)?

Andrew Paine with lowest potential downside - -$204.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?